Australia markets open in 8 hours 11 minutes

Alaunos Therapeutics, Inc. (TCRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2400-0.0900 (-6.77%)
At close: 04:00PM EDT
1.2800 +0.04 (+3.23%)
After hours: 05:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 19.86M
Enterprise value 13.79M
Trailing P/E 4.35
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)264.46
Price/book (mrq)3.15
Enterprise value/revenue 38.60
Enterprise value/EBITDA -3.55

Trading information

Stock price history

Beta (5Y monthly) -0.26
52-week change 3-87.28%
S&P500 52-week change 326.27%
52-week high 310.5000
52-week low 30.6000
50-day moving average 31.5930
200-day moving average 31.9479

Share statistics

Avg vol (3-month) 370.14k
Avg vol (10-day) 336.07k
Shares outstanding 516.01M
Implied shares outstanding 616.01M
Float 813.08M
% held by insiders 114.30%
% held by institutions 116.92%
Shares short (30 Apr 2024) 41.47M
Short ratio (30 Apr 2024) 428.42
Short % of float (30 Apr 2024) 410.64%
Short % of shares outstanding (30 Apr 2024) 49.16%
Shares short (prior month 28 Mar 2024) 41.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 301 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-336,000.00%

Management effectiveness

Return on assets (ttm)-48.66%
Return on equity (ttm)-156.66%

Income statement

Revenue (ttm)5k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-90.90%
Gross profit (ttm)N/A
EBITDA -26.18M
Net income avi to common (ttm)-35.14M
Diluted EPS (ttm)-33.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.06M
Total cash per share (mrq)0.38
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.22
Book value per share (mrq)0.39

Cash flow statement

Operating cash flow (ttm)-30.14M
Levered free cash flow (ttm)-5.1M